Neuronetics
STIM
83 hedge funds and large institutions have $59.9M invested in Neuronetics in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 27 increasing their positions, 30 reducing their positions, and 12 closing their positions.
25% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 12
4% more funds holding
Funds holding: 80 → 83 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.97% less ownership
Funds ownership: 75.79% → 74.83% (-0.97%)
10% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 30
33% less capital invested
Capital invested by funds: $89M → $59.9M (-$29.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$2.97M |
| 2 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
+$1.28M |
| 3 |
Millennium Management
New York
|
+$1.07M |
| 4 |
Renaissance Technologies
New York
|
+$629K |
| 5 |
First Eagle Investment Management
New York
|
+$404K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.2M |
| 2 |
PGM
Parian Global Management
Pound Ridge,
New York
|
-$1.57M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$1.17M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$490K |
| 5 |
RA
Royce & Associates
New York
|
-$450K |
STIM Hedge Fund Activity: Q1 2022 in Review
83 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Neuronetics (STIM) for Q1 2022, worth a combined $59.9M — down 33% from $89M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new STIM positions and 12 closed out — a net gain of 3 holders — while 27 added to existing stakes and 30 trimmed.
The largest buyer was Nantahala Capital Management, opening a new position worth an estimated $2.97M. The largest seller was Fidelity Investments, cutting an estimated $3.2M.
- 83 institutional investors held Neuronetics (STIM) as of Q1 2022, up from 80 in Q4 2021.
- Funds reported $59.9M of Neuronetics stock for Q1 2022, down 33% quarter-over-quarter.
- 15 funds opened new Neuronetics positions in Q1 2022 and 12 closed out, a net change of +3 holders.
- The largest Neuronetics buyer in Q1 2022 was Nantahala Capital Management, an estimated $2.97M added.
- The largest Neuronetics seller in Q1 2022 was Fidelity Investments, an estimated $3.2M sold.
Based on aggregated 13F filings for Q1 2022.